HopeStage
Back to all studies
RecruitingNCT07322432

VapeAway to support quitting vaping through gradual nicotine reduction

About this titleRead the official source — NCT07322432
Device studyAges 21+United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: from 21 years.

Listed locations
New YorkSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: December 24, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
70
Sponsor
VapeAway
Sponsor type
Unknown or unclear
Study type
Device
Intervention type
Device
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
Over 21 Years
Official registry ID
NCT07322432
Official title
Show the full official title

The CONQUER Trial: Cessation Of Nicotine, QUitting With E-cigarette Reduction - A Single-Arm, Open-Label Clinical Trial to Assess the Efficacy of VapeAway in Promoting Vaping Cessation Compared to Historical Rates of Vaping Cessation

Recruitment & locations

Currently recruiting

New York

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is VapeAway.

Who can participate?

Listed age limits: from 21 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies